Disparities in OUD treatment: Buprenorphine vs. naltrexone
Understanding disparities in opioid use disorder (OUD) treatment Pharmaceutical companies committed...
A recent CNBC article used HealthVerity real-world data (RWD) to highlight a shortage of estrogen patches that is visible in RWD as demand for menopause support skyrockets. Menopause affects millions of women, yet it has long remained one of the...
Understanding disparities in opioid use disorder (OUD) treatment Pharmaceutical companies committed...
(Part 1) When clients see real-world data (RWD) in HealthVerity Marketplace, it may appear...
Electronic Health Records (EHR): What they are and how to use them in real-world data Electronic...
Antiretroviral therapy (ART) has transformed outcomes for people living with HIV, especially those...
In this edition of our Ask an Expert series, we turn to Emery Niemiec, Senior Director,...
Mapping food allergy care with omalizumab and real-world data IgE-mediated food allergies (FAs)...
High-risk NMIBC: Disease overview and treatment approach Johnson & Johnson quickly identified and...
Government health agencies are increasingly turning to real-world data (RWD) for public health...
HealthVerity recently introduced HealthVerity Notes, our newest product designed to unlock the...
AI-driven mortality models are supposed to provide accurate, data-backed insights into patient...
Healthcare data now accounts for approximately 30% of global data volume and with this surge in data, life sciences organizations have access to more information than ever before. Some disruptions expand what you can do: new data owners entering the ...